Ms. Najla Guthrie, President/CEO is an internationally recognized scientist in the field of nutrition and breast cancer. Her original research, conducted at the Centre for Human Nutrition of the University of Western Ontario, focused on the anti-cancer effects of minor food components, flavonoids, limonoids and tocotrienols, in cell culture, animal models and clinical trials. Ms. Guthrie has published over 32 papers in peer-reviewed journals and has given numerous invited presentations at national and international scientific and industry events. Her research, which has demonstrated the anti-cancer properties of citrus juices and their constituent flavonoids, continues to generate a tremendous amount of scientific and media interest.
A founding shareholder, Ms. Guthrie has successfully transitioned from a nutraceutical medicines researcher to CEO of KGK. The Company has under her leadership established, and executed on, a strategic plan to leverage its research infrastructure and generate sufficient capital to finance the development of new and patented nutraceutical product groups of its own. Ms. Guthrie has led and managed the Company's profitable growth of its contract research business over the past twelve years; and has been responsible for recruitment of an integrated research and product development team that today maintains a reputation for world-class nutraceutical science. Ms. Guthrie is responsible for the strategic development of the patenting process, marketing and sales strategies and business development. She is also responsible for the commercialization and licensing of KGK's cholesterol reduction product currently being marketed. In addition, Ms. Guthrie is widely recognized as a leading nutraceutical industry expert and spokesperson; as well as being active in several nutraceutical industry groups.
September 15, 2011